Abstract
The effective capture, release and reanalysis of circulating tumor cells (CTCs) are of great significance to acquire tumor information and promote the progress of tumor therapy. Particularly, the selective release of multiple types of CTCs is critical to further study; however, it is still a great challenge. To meet this challenge, we designed a smart DNAzyme probe-based platform. By combining multiple targeting aptamers and multiple metal ion responsive DNAzymes, efficient capture and selective release of multiple types CTCs were realized. Sgc8c aptamer integrated Cu2+-dependent DNAzyme and TD05 aptamer integrated Mg2+-dependent DNAzyme can capture CCRF-CEM cells and Ramos cells respectively on the substrate. With the addition of Cu2+ or Mg2+, CCRF-CEM cells or Ramos cells will be released from the substrate with specific selectivity. Furthermore, our platform has been successfully demonstrated in the whole blood sample. Therefore, our capture/release platform will benefit research on the molecular analysis of CTCs after release and has great potential for cancer diagnosis and individualized treatment.
Highlights
Circulating tumor cells (CTCs) are a class of cancer cells present in peripheral blood which cast off from the primary tumor into peripheral blood.[1,2] The detection and isolation of circulating tumor cells (CTCs) are of vital importance for the early diagnosis of cancer, monitoring of therapeutic efficacy and evaluation of treatment.[3,4,5,6] Since the amount of CTCs is extremely exiguous in patients' blood,[7,8,9] there is an imperative demand to capture and enrich CTCs with high efficiency
In order to observe the cells clearly, CCRF-CEM cells were stained with calcein AM for 10 min while Ramos cells were stained with DAPI 15 min a er incubation
A er the successful release of CTCs by metal ions, we explored the viability of released CTCs with live/dead cell staining with calcein AM and propidium iodide (PI)
Summary
Circulating tumor cells (CTCs) are a class of cancer cells present in peripheral blood which cast off from the primary tumor into peripheral blood.[1,2] The detection and isolation of CTCs are of vital importance for the early diagnosis of cancer, monitoring of therapeutic efficacy and evaluation of treatment.[3,4,5,6] Since the amount of CTCs is extremely exiguous in patients' blood,[7,8,9] there is an imperative demand to capture and enrich CTCs with high efficiency . Sgc8c aptamer integrated Cu2+-dependent DNAzyme and TD05 aptamer integrated Mg2+-dependent DNAzyme can capture CCRF-CEM cells and Ramos cells respectively on the substrate. With the addition of Cu2+ or Mg2+, CCRF-CEM cells or Ramos cells will be released from the substrate with specific selectivity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.